Literature DB >> 15086316

Slow-tight-binding inhibition of enoyl-acyl carrier protein reductase from Plasmodium falciparum by triclosan.

Mili Kapoor1, C Chandramouli Reddy, M V Krishnasastry, Namita Surolia, Avadhesha Surolia.   

Abstract

Triclosan is a potent inhibitor of FabI (enoyl-ACP reductase, where ACP stands for acyl carrier protein), which catalyses the last step in a sequence of four reactions that is repeated many times with each elongation step in the type II fatty acid biosynthesis pathway. The malarial parasite Plasmodium falciparum also harbours the genes and is capable of synthesizing fatty acids by utilizing the enzymes of type II FAS (fatty acid synthase). The basic differences in the enzymes of type I FAS, present in humans, and type II FAS, present in Plasmodium, make the enzymes of this pathway a good target for antimalarials. The steady-state kinetics revealed time-dependent inhibition of FabI by triclosan, demonstrating that triclosan is a slow-tight-binding inhibitor of FabI. The inhibition followed a rapid equilibrium step to form a reversible enzyme-inhibitor complex (EI) that isomerizes to a second enzyme-inhibitor complex (EI*), which dissociates at a very slow rate. The rate constants for the isomerization of EI to EI* and the dissociation of EI* were 5.49x10(-2) and 1x10(-4) s(-1) respectively. The K(i) value for the formation of the EI complex was 53 nM and the overall inhibition constant K(i)* was 96 pM. The results match well with the rate constants derived independently from fluorescence analysis of the interaction of FabI and triclosan, as well as those obtained by surface plasmon resonance studies [Kapoor, Mukhi, N. Surolia, Sugunda and A. Surolia (2004) Biochem. J. 381, 725-733].

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086316      PMCID: PMC1133881          DOI: 10.1042/BJ20031821

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  Tight-binding inhibitors--III. A new approach for the determination of competition between tight-binding inhibitors and substrates--inhibition of adenosine deaminase by coformycin.

Authors:  S Cha
Journal:  Biochem Pharmacol       Date:  1976-12-15       Impact factor: 5.858

2.  Overproduction of beta-ketoacyl-acyl carrier protein synthase I imparts thiolactomycin resistance to Escherichia coli K-12.

Authors:  J T Tsay; C O Rock; S Jackowski
Journal:  J Bacteriol       Date:  1992-01       Impact factor: 3.490

Review 3.  Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesis.

Authors:  C O Rock; J E Cronan
Journal:  Biochim Biophys Acta       Date:  1996-07-12

4.  Slow-binding inhibition: the general case.

Authors:  M J Sculley; J F Morrison; W W Cleland
Journal:  Biochim Biophys Acta       Date:  1996-11-14

5.  Composition, fluorescence, and circular dichroism of rat lysozyme.

Authors:  R S Mulvey; R J Gualtieri; S Beychok
Journal:  Biochemistry       Date:  1974-02-12       Impact factor: 3.162

Review 6.  The behavior and significance of slow-binding enzyme inhibitors.

Authors:  J F Morrison; C T Walsh
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1988

7.  The kinetics of reversible tight-binding inhibition.

Authors:  J W Williams; J F Morrison
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

8.  Evaluation of methods for estimating the dissociation constant of tight binding enzyme inhibitors.

Authors:  W R Greco; M T Hakala
Journal:  J Biol Chem       Date:  1979-12-10       Impact factor: 5.157

9.  A mechanism of drug action revealed by structural studies of enoyl reductase.

Authors:  C Baldock; J B Rafferty; S E Sedelnikova; P J Baker; A R Stuitje; A R Slabas; T R Hawkes; D W Rice
Journal:  Science       Date:  1996-12-20       Impact factor: 47.728

10.  Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli.

Authors:  R J Heath; C O Rock
Journal:  J Biol Chem       Date:  1995-11-03       Impact factor: 5.157

View more
  17 in total

1.  Dynamics of Plasmodium falciparum enoyl-ACP reductase and implications on drug discovery.

Authors:  Steffen Lindert; J Andrew McCammon
Journal:  Protein Sci       Date:  2012-10-09       Impact factor: 6.725

2.  Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target.

Authors:  Ina L Lauinger; Livia Vivas; Remo Perozzo; Christopher Stairiker; Alice Tarun; Mire Zloh; Xujie Zhang; Hua Xu; Peter J Tonge; Scott G Franzblau; Duc-Hung Pham; Camila V Esguerra; Alexander D Crawford; Louis Maes; Deniz Tasdemir
Journal:  J Nat Prod       Date:  2013-06-19       Impact factor: 4.050

3.  Rationalizing the Binding Kinetics for the Inhibition of the Burkholderia pseudomallei FabI1 Enoyl-ACP Reductase.

Authors:  Carla Neckles; Sandra Eltschkner; Jason E Cummings; Maria Hirschbeck; Fereidoon Daryaee; Gopal R Bommineni; Zhuo Zhang; Lauren Spagnuolo; Weixuan Yu; Shabnam Davoodi; Richard A Slayden; Caroline Kisker; Peter J Tonge
Journal:  Biochemistry       Date:  2017-03-21       Impact factor: 3.162

4.  Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay.

Authors:  Gustavo A Afanador; Stephen P Muench; Martin McPhillie; Alina Fomovska; Arne Schön; Ying Zhou; Gang Cheng; Jozef Stec; Joel S Freundlich; Hong-Ming Shieh; John W Anderson; David P Jacobus; David A Fidock; Alan P Kozikowski; Colin W Fishwick; David W Rice; Ernesto Freire; Rima McLeod; Sean T Prigge
Journal:  Biochemistry       Date:  2013-12-13       Impact factor: 3.162

5.  Selectivity of Pyridone- and Diphenyl Ether-Based Inhibitors for the Yersinia pestis FabV Enoyl-ACP Reductase.

Authors:  Carla Neckles; Annica Pschibul; Cheng-Tsung Lai; Maria Hirschbeck; Jochen Kuper; Shabnam Davoodi; Junjie Zou; Nina Liu; Pan Pan; Sonam Shah; Fereidoon Daryaee; Gopal R Bommineni; Cristina Lai; Carlos Simmerling; Caroline Kisker; Peter J Tonge
Journal:  Biochemistry       Date:  2016-05-17       Impact factor: 3.162

6.  Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.

Authors:  Jozef Stec; Alina Fomovska; Gustavo A Afanador; Stephen P Muench; Ying Zhou; Bo-Shiun Lai; Kamal El Bissati; Mark R Hickman; Patty J Lee; Susan E Leed; Jennifer M Auschwitz; Caroline Sommervile; Stuart Woods; Craig W Roberts; David Rice; Sean T Prigge; Rima McLeod; Alan P Kozikowski
Journal:  ChemMedChem       Date:  2013-06-14       Impact factor: 3.466

Review 7.  New advances in fatty acids as antimalarial, antimycobacterial and antifungal agents.

Authors:  N M Carballeira
Journal:  Prog Lipid Res       Date:  2007-11-01       Impact factor: 16.195

8.  Trapping of the Enoyl-Acyl Carrier Protein Reductase-Acyl Carrier Protein Interaction.

Authors:  Lorillee Tallorin; Kara Finzel; Quynh G Nguyen; Joris Beld; James J La Clair; Michael D Burkart
Journal:  J Am Chem Soc       Date:  2016-03-15       Impact factor: 15.419

9.  Kinetic and structural analysis of the increased affinity of enoyl-ACP (acyl-carrier protein) reductase for triclosan in the presence of NAD+.

Authors:  Mili Kapoor; P L Swarna Mukhi; Namita Surolia; K Suguna; Avadhesha Surolia
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

10.  Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase.

Authors:  Lorillee C Tallorin; Jacob D Durrant; Quynh G Nguyen; J Andrew McCammon; Michael D Burkart
Journal:  Bioorg Med Chem       Date:  2014-09-15       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.